RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

Dades bibliogràfiques
Autors principals:	Seeman, E, Chapurlat, R, Cheung, A, Felsenberg, D, La-Roche, M, Reeve, J, Thomas, T, Zanchetta, J, Bock, O, Morris, E, Tile, L, D'Alo, G, Darbie, L, Borah, B, Rizzoli, R
Format:	Journal article
Publicat:	2010

Ítems similars

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
per: Bala, Y, et al.
Publicat: (2014)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
per: Stefano Palomba, et al.
Publicat: (2010-06-01)

Risedronate or exercise for lean mass preservation during menopause: secondary analysis of a randomized controlled trial
per: Laura E. Flores, et al.
Publicat: (2022-07-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
per: Seeman, A, et al.
Publicat: (2000)

Risedronate-loaded aerogel scaffolds for bone regeneration
per: Nahla El-Wakil, et al.
Publicat: (2023-12-01)

Once-monthly risedronate for postmenopausal osteoporosis
per: Kristina Casadei, et al.
Publicat: (2009-02-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
per: Raja Bobba, et al.
Publicat: (2007-10-01)

Reversal deterioration of renal function accompanied with primary hypothyrodism
per: Dragović Tamara
Publicat: (2012-01-01)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
per: Duncan, E, et al.
Publicat: (2005)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
per: Ma. Florencia Peralta, et al.
Publicat: (2021-05-01)

Effect of risedronate on bone loss at discontinuation of denosumab
per: Michel Laroche, et al.
Publicat: (2020-12-01)

Risedronate inhibits human osteosarcoma cell invasion
per: Jung Sung, et al.
Publicat: (2009-07-01)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
per: Eliska Vaculikova, et al.
Publicat: (2014-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
per: Diane Kleinermans, et al.
Publicat: (2022-06-01)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement
per: Utari, Tita Ratya, et al.
Publicat: (2022)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
per: Abdurrahman Yeter, et al.
Publicat: (2014-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
per: Roelofs, A, et al.
Publicat: (2005)

The Effect of Menopause on Antipsychotic Response
per: Alexandre González-Rodríguez, et al.
Publicat: (2022-10-01)

Spectrophotometric Determination of Risedronate Sodium in Pharmaceutical Preparations by Derivative and Continuous Wavelet Transforms
per: Uğurlu, G., et al.
Publicat: (2008-12-01)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
per: Kashemirov, B, et al.
Publicat: (2008)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
per: Yohei Asada, et al.
Publicat: (2019-01-01)

The Effects of Risedronate Treatment on the Pain and the Quality of Life - Original Investigation
per: Evrim Karadağ Saygı, et al.
Publicat: (2009-08-01)

Development of Risedronate-Loaded Nano Capsules for Calvaria Healing in Rabbit
per: Hesam Aldin Hoseinzadeh, et al.
Publicat: (2019-04-01)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
per: María J Moro-Álvarez, et al.
Publicat: (2008-06-01)

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
per: Sorensen, O, et al.
Publicat: (2003)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
per: Marma, MS, et al.
Publicat: (2007)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
per: Coxon, F, et al.
Publicat: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
per: Coxon, F, et al.
Publicat: (2008)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
per: Tahir Masud, et al.
Publicat: (2009-11-01)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
per: Shabnam Aghayan, et al.
Publicat: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
per: Vincenzo Monda, et al.
Publicat: (2017-09-01)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
per: Amy L. Inselman, et al.
Publicat: (2024-04-01)

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
per: Sugiyama, T, et al.
Publicat: (2011)

Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration
per: Tomasz Miazgowski, et al.
Publicat: (2012-01-01)

The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
per: Alexandre González-Rodríguez, et al.
Publicat: (2019-07-01)

Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors
per: Kolmas J, et al.
Publicat: (2017-08-01)

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
per: Brounais-Le Royer, B, et al.
Publicat: (2012)

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
per: Cooper, C, et al.
Publicat: (2001)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
per: Kavanagh, K, et al.
Publicat: (2006)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
per: Mabilleau, G, et al.
Publicat: (2011)